James Hassard, Chief Commercial Officer at Crinetics Pharmaceuticals, Inc. (CRNX), sold 15,000 shares at $44.66 ($670K) on 2024-06-21, disclosed to the SEC on 2024-06-24.
Scheduled sale ($670k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ARWR | SELL | 2021-01-08 | $1.2M | — | Filing → |